Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2c1255f214139ff3c830c810709d18e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-515 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49fc8259a39311f93442eb3cacf175e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f94ad385271a5e37454f19bba4ee48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c0427c5be655b64a3ff9781a812594e |
publicationDate |
2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9820988-B2 |
titleOfInvention |
Treatment of epileptic disorders in feline animals |
abstract |
The present invention relates to the use of 1-(4-chlorophenyl)-4-(4-morpholinyl)-2.5-dihydro-1H-imidazol-2-one or a physiologically acceptable salt thereof in a method for treatment and/or prevention of one or more epileptic disorders in a feline animal, preferably a cat. |
priorityDate |
2014-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |